Elomia Alternatives in 2026: 7 Options Actually Worth Trying
Elomia is a CBT-informed AI mental-health chatbot offering 24/7 anonymous emotional support, with consumer subscriptions in the typical $10โ15/month range pl
Fact-checked against vendor sources โ 90/100 ยท October 4, 2026
Elomia is a CBT-informed AI mental-health chatbot offering 24/7 anonymous emotional support, with consumer subscriptions in the typical $10โ15/month range plus annual and lifetime options, and a 4.5/5 rating across about 1.1K App Store ratings. If you want a companionship-style experience rather than a wellbeing tool, FlirtAlly is a live alternative with a free tier (no account needed) and paid plans from $9.99/month. For strictly clinical validation, Wysa โ with 30+ peer-reviewed publications โ remains the stronger choice.Bottom line: There is no single winner: Elomia is the strongest conversational wellbeing companion, Wysa leads on clinical evidence, and FlirtAlly is the pick if you want an entertainment/relationship companion with games, calls, and memory rather than therapeutic support.
TL;DR
- Elomia is a CBT-informed AI companion for anxiety, stress, low mood, and relationships, available 24/7 on iOS, Android, and web.
- Elomia's iOS app holds a 4.5/5 rating from about 1.1K ratings, with a 3-day free trial before auto-renewing subscriptions.
- Consumer subscriptions run in the typical $10โ15/month range, with annual and lifetime options; employer pricing is negotiated per-employee-per-month.
- Elomia reports 85% of users feel better after their first conversation, and 34% of sessions happen after midnight when traditional services are unavailable.
- Its main evidence gap: no portfolio of peer-reviewed RCTs comparable to Wysa's 30+ publications; a University of Pennsylvania RCT is still in progress.
- FlirtAlly is the alternative if you want a companionship experience โ 22 official companions, 16 games, real phone numbers, 2-way email, and physical mail โ free to start with paid plans from $9.99/month.
- Woebot's consumer app shut down in June 2025, so it is no longer a viable consumer option despite strong prior clinical research.
Researched everything on Elomia โ verified pricing, the feature-by-feature grid, and where it genuinely wins.
Full Elomia profile โ